Vimarsana
Biggest News Aggregation in the World

While Starton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Starton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Starton Today - Breaking & Trending Today

Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions - Vimarsana News

Healthwell Acquisition Corp. I Announces Postponement of the Special Meeting of Stockholders to Approve the Proposed Business Combination with Starton Therapeutics, Inc. and Related Transactions

Healthwell Acquisition Corp. I announced today that it has postponed until further announcement the date of the special meeting of the Company’s stockholders to approve its proposed business...

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions - Vimarsana News

Healthwell Acquisition Corp. I Announces New Meeting Date for the Special Meeting of Stockholders to Approve Proposed Business Combination With Starton Therapeutics, Inc. and Related Transactions

Healthwell Acquisition Corp. I announced today that it has postponed the date of the special meeting of the Company’s stockholders to approve its proposed business combination with Starton...

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phas - Vimarsana News

Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phas

Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”...

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase - Vimarsana News

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myelomaTreatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with STAR-LLDPARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical s...

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma - Vimarsana News

Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma Treatment regimen will include Velcade® and dexamethasone and replace oral... | June 12, 2023